Konstantinos Voumvourakis Selected Research

Konstantinos Voumvourakis Research Topics

Disease

13	Ischemic Stroke 01/2021 - 11/2011
11	Stroke (Strokes) 12/2021 - 11/2011
7	Multiple Sclerosis 02/2022 - 09/2014
3	Atherosclerosis 12/2021 - 03/2016
3	Atrial Fibrillation 05/2017 - 05/2014
3	Transient Ischemic Attack 01/2017 - 05/2014
3	Relapsing-Remitting Multiple Sclerosis 01/2016 - 01/2015
2	Neurologic Manifestations (Neurological Manifestations) 02/2022 - 01/2022
2	Nervous System Diseases (Neurological Disorders) 02/2022 - 01/2017
2	Hemorrhagic Stroke 01/2021 - 09/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2017 - 09/2016
2	Hemorrhage 09/2016 - 05/2014
2	Atrophy 09/2015 - 01/2015
2	Disease Progression 01/2015 - 07/2005
2	Fatigue 09/2014 - 07/2014
2	Hypertension (High Blood Pressure) 05/2014 - 05/2013
1	Encephalomyelitis (Myeloencephalitis) 02/2022
1	Guillain-Barre Syndrome 02/2022
1	Inflammation (Inflammations) 12/2021
1	Atherosclerotic Plaque (Atheroma) 12/2021
1	Foreign-Body Reaction 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Pulmonary Arterial Hypertension 01/2020
1	Hyperglycemia 09/2019
1	Hypoglycemia (Reactive Hypoglycemia) 09/2019
1	Vasculitis (Vasculitides) 11/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2017
1	Cerebral Hemorrhage 01/2017
1	Patent Foramen Ovale 09/2016
1	Venous Insufficiency 01/2016
1	Hyperemia 01/2016
1	Cognitive Dysfunction 08/2015
1	Hypothyroidism 08/2015
1	Necrosis 07/2015
1	Hydrocephalus (Hydrocephaly) 01/2015
1	Thrombosis (Thrombus) 01/2015
1	Myasthenia Gravis 06/2014
1	Diabetes Mellitus 05/2014
1	Myocardial Infarction 05/2014
1	Heart Failure 05/2014
1	Dyspepsia (Indigestion) 05/2014
1	Embolism (Embolus) 05/2014
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 05/2014
1	Neuromyelitis Optica (Devic's Disease) 01/2014
1	Exanthema (Rash) 01/2014
1	Arthralgia (Joint Pain) 01/2014
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 09/2013
1	Alcoholism (Alcohol Abuse) 09/2013

Drug/Important Bio-Agent (IBA)

3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2022 - 03/2016
3	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 04/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2014
3	InterferonsIBA 01/2020 - 10/2017
2	AutoantibodiesIBA 02/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 11/2018 - 06/2014
2	Dabigatran FDA Link 09/2016 - 05/2014
2	mesoglycanIBA 09/2015 - 11/2014
2	EnzymesIBA 08/2015 - 09/2010
2	Adenosine Triphosphatases (ATPase)IBA 08/2015 - 09/2013
2	Biological ProductsIBA 09/2014 - 07/2014
1	Angiotensin-Converting Enzyme 2IBA 02/2022
1	Ad26COVS1IBA 02/2022
1	Neuropilin-1IBA 02/2022
1	Cell Surface ReceptorsIBA 02/2022
1	Coenzyme A (CoA)IBA 02/2022
1	Oxidoreductases (Dehydrogenase)IBA 02/2022
1	AdipokinesIBA 12/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	SynucleinsIBA 01/2021
1	Tenecteplase FDA Link 01/2021
1	Dimethyl FumarateIBA 10/2017
1	Glial Fibrillary Acidic ProteinIBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2016
1	RivaroxabanIBA 09/2016
1	AnticoagulantsIBA 09/2016
1	N-benzoyl-N-phenylhydroxylamineIBA 01/2016
1	nitazoxanide (NTZ)FDA Link 01/2016
1	IronIBA 01/2016
1	Natalizumab (Tysabri)FDA Link 01/2016
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016
1	Thyroid HormonesIBA 08/2015
1	Propylthiouracil FDA Link 08/2015
1	U 74389FIBA 07/2015
1	InterleukinsIBA 07/2015
1	Cholinergic ReceptorsIBA 06/2014
1	AntibodiesIBA 06/2014
1	Lipoprotein Receptors (Lipoprotein Receptor)IBA 06/2014
1	Immunoglobulin G (IgG)IBA 01/2014
1	Antinuclear AntibodiesIBA 01/2014
1	Thiamine (Aneurin)FDA Link 09/2013
1	AntioxidantsIBA 09/2013

Therapy/Procedure

12	Therapeutics 01/2021 - 05/2014
2	Thrombectomy 01/2021 - 09/2019
2	Secondary Prevention 11/2020 - 09/2016
1	Stents 01/2015
1	Duration of Therapy 01/2015
1	Length of Stay 05/2014